Afinitor Disperz
Afinitor Disperz ingredients
| Active ingredient | Strength |
|---|---|
| Everolimus | 5 mg/1, 2 mg/1, 3 mg/1 |
What Afinitor Disperz is used for
The FDA lists the approved uses on the official label (below). In the EU, everolimus is approved as Afinitor for:
Hormone-receptor-positive advanced breast cancer Afinitor is indicated for the treatment of hormone-receptor-positive, HER2/neu-negative advanced breast cancer, in combination with exemestane, in post-menopausal women without symptomatic visceral disease after recurrence or progression following a non-steroidal aromatase inhibitor. Neuroendocrine tumours of pancreatic origin Afinitor is indicated for the treatment of unresectable or metastatic, well or moderately differentiated neuroendocrine tumours of pancreatic origin in adults with progressive disease. Neuroendocrine tumours of gastrointestinal or lung origin Afinitor is indicated for the treatment of unresectable or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease. Renal-cell carcinoma Afinitor is indicated for the treatme…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Afinitor Disperz
- Generic name
- Everolimus
- Made by
- Novartis Pharmaceuticals Corporation
- Forms
- Tablet, For Suspension
- Given
- Oral
- Drug class
- Kinase Inhibitor, mTOR Inhibitor Immunosuppressant
- FDA approval
- New drug application (NDA) NDA203985
- On the US market since
- 2012
Official information
- Afinitor Disperz prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Everolimus)
In India
- Everolimus: 34 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Afinitor Disperz?
Afinitor Disperz (Everolimus) is a cancer medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.
What are the ingredients of Afinitor Disperz?
Afinitor Disperz contains Everolimus (5 mg/1, 2 mg/1, 3 mg/1).
Is Afinitor Disperz approved in Europe?
The same active substance is approved in the EU as Afinitor, Votubia.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA